Identification of asthma phenotypes in a tertiary care medical center

American Journal of the Medical Sciences

Volumn 348, Issue 6, 2014, Pages 480-485

  Kuhlen, James L ^a   Wahlquist, Amy E ^a   Nietert, Paul J ^a   Bains, Sonia N ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Asthma; Cluster; Phenotype; Severe

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MONTELUKAST; OMALIZUMAB; THEOPHYLLINE; ZILEUTON;

ADULT; AFRICAN AMERICAN; AGED; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; COMORBIDITY; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG USE; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE UNIT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NOCTURNAL ASTHMA; OBESITY; ONSET AGE; PHENOTYPE; PHYSICIAN; RETROSPECTIVE STUDY; SEVERE PERSISTENT ASTHMA; SLEEP DISORDERED BREATHING; SMOKING; TERTIARY CARE CENTER; TREATMENT RESPONSE; ALGORITHM; CLASSIFICATION; COHORT ANALYSIS; DISEASE COURSE; HEALTH SERVICE; HYPERSENSITIVITY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; UTILIZATION; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; AGE OF ONSET; AGED; ALGORITHMS; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SERVICES; HUMANS; HYPERSENSITIVITY; LUNG; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84922391720     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000346     Document Type: Article

References (20)

1. Wenzeh S. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 2012;18:716-25.
2. The morbidity & mortality: chart book on cardiovascular, lung, and blood diseases. Bethesda, MD: National Heart Lung and Blood Institute; 2009.
3. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120(5 suppl):S94-138.
4. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; National Heart, Lung, and Blood Institute; 2007. Publication no. 07-4051.
5. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78.
6. Fuhrman C, Dubus JC, Marguet C, et al. Hospitalizations for asthma in children are linked to undertreatment and insufficient asthma education. J Asthma 2011;48:565-71.
7. Global Initiative for Asthma. Global strategy for asthma management and prevention (GINA). National Institutes of Health. Bethesda, MD: National Heart, Lung, and Blood Institute.
8. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: A randomised controlled trial. Lancet 2008;372:1065-72.
9. Guibas GV, Makris M, Papadopoulos NG. Acute asthma exacerbations in childhood: risk factors, prevention and treatment. Expert Rev Respir Med 2012;6:629-38.
10. Boulay ME, Boulet LP. Discordance between asthma control clinical, physiological and inflammatory parameters in mild asthma. Respir Med 2013;107:511-8.
11. O-Byrne PM. Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Am J Respir Crit Care Med 2005; 172:410-12.
12. Hanania NA, Alpan O, Hamilos DL, et al. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: A randomized trial. Ann Intern Med 2011;154:573-82.
13. Boushey HA. Daily inhaled corticosteroid treatment should not be prescribed for mild persistent asthma. Am J Respir Crit Care Med 2005; 172:410-12.
14. Diette GB, Krishnan JA, Dominici F, et al. Asthma in older patients: factors associated with hospitalization. Arch Intern Med 2002;162:1123-32.
15. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218-24.
16. Rao CK, Moore CG, Bleecker E, et al. Characteristics of perimenstrual asthma (PMA) and its relation to asthma severity and control: data from the severe asthma research program. Chest 2013;143:984-92.
17. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Resp Crit Care Med 2010;181:315-23.
18. Patrawalla P, Kazeros A, Rogers L, et al. Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population. PloS One 2012;7:e44540.
19. National Institutes of Health and National Heart, Lung, and Blood Institute; Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda (MD): National Institutes of Health; 2002. NIH Publication 02-3659.
20. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-13.